All Stories

  1. An Individualized Right-to-Left Tunneling “Bail-Out” for Complex ICD Upgrade in a Pacemaker-Dependent Patient: A Case Report and Literature Review
  2. Quantifying the Learning Curve in Ultrasound-Guided Vascular Access: Proficiency Metrics of Self-Taught Axillary Vein Puncture for CIED Implantation
  3. Association of the Triglyceride–Glucose Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis
  4. Wearable Devices for Quantifying Atrial Fibrillation Burden: A Systematic Review and Bayesian Meta-Analysis
  5. Cryoballoon Pulmonary Vein Isolation in Obese Patients with Atrial Fibrillation Compared to Non-Obese Counterparts: A Meta-Analysis
  6. Epicardial Adipose Tissue and Atrial Fibrillation Recurrence following Catheter Ablation: A Systematic Review and Meta-Analysis
  7. Efficacy, Safety and Feasibility of Superior Vena Cava Isolation in Patients Undergoing Atrial Fibrillation Catheter Ablation: An Up-to-Date Review
  8. Advances in the Management of Heart Failure with Reduced Ejection Fraction; The Role of SGLT2is, ARNI, Myotropes, Vericiguat, and Anti-inflammatory Agents: A Mini-review
  9. A call for shorter blanking period, time to get off the ground
  10. Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-of-the-Art Review
  11. Left Distal Radial Artery Access for Coronary Angiography and Interventions: A 12-Month All-Comers Study
  12. Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis
  13. Early arrhythmia recurrence after cryoballoon ablation in atrial fibrillation: A systematic review and meta‐analysis
  14. Colchicine in Cardiovascular Disease: In-Depth Review
  15. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
  16. Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations
  17. Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
  18. Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review
  19. Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations
  20. Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis
  21. Heroes, politics and media: the unshakable medical practice in the pandemic
  22. Colchicine administered early in acute myocardial infarction: ready, set … go?
  23. Repurposing colchicine’s journey in view of drug-to-drug interactions. A review
  24. Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
  25. The role of cardiology specialties in times of crisis
  26. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
  27. Visually Guided Laser Ablation for Atrial Fibrillation: First experience in Greece
  28. Arteriosclerosis and arterial remodeling; different mechanisms in young adults
  29. Usefulness of a Structured Adult Education Program in Modifying Markers of Cardiovascular Risk After Acute Myocardial Infarction
  30. “TAVI: Valve in valve. A new field for structuralists? Literature review”
  31. Are Drugs Always the Proper Solution to Therapeutic Dilemmas? Non-drug Approaches to the Post-traumatic Stress “Waking Corpse” Syndrome
  32. The Role of Calcium Handling Mechanisms in Reperfusion Injury
  33. The Role of Colchicine in Treating Postoperative and Post–Catheter Ablation Atrial Fibrillation
  34. Colchicum Genus in the Writings of Ancient Greek and Byzantine Physicians
  35. Invasive treatment in peripheral artery disease
  36. Ambulatory Pulse Wave Velocity Monitoring
  37. Permanent pacemaker implantation in octogenarians with unexplained syncope and positive electrophysiologic testing
  38. Remote Ischemic Conditioning and Renal Protection
  39. Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
  40. Peri-procedural Anticoagulation in Catheter Ablation for Atrial Fibrillation: A Review
  41. Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI
  42. Genetics in the Clinical Decision of Antiplatelet Treatment
  43. Editorial: Antiplatelet and Anticoagulation Treatment in Special Populations
  44. In Vivo Assessment of Atherosclerotic Plaque Neovascularization by Contrast-Enhanced Ultrasound: An Unsolved Mystery?
  45. Impact of balloon aortic valvuloplasty on transcatheter aortic valve implantation with self-expandable valve
  46. Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence
  47. Correlation of CoreValve implantation ‘true cover index’ with short and mid-term aortic regurgitation: A novel index
  48. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis
  49. Assessment of the vulnerable carotid atherosclerotic plaque using contrast-enhanced ultrasonography
  50. Circulating Erythrocyte Microparticles and the Biochemical Extent of Myocardial Injury in ST Elevation Myocardial Infarction
  51. Mean arterial pressure values calculated using seven different methods and their associations with target organ deterioration in a single-center study of 1878 individuals
  52. Editorial: Bioengineering, Clinical and Therapeutical Trends in Transcatheter Aortic Valve Implantation
  53. Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations
  54. Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations
  55. Jean-Baptiste de Senac's (1693-1770) Important Work on Cardiology and Valvular Disorders
  56. A Preliminary Study on In-Vivo 3-D Imaging of Bioprosthetic Aortic Valve Deformation
  57. Central Blood Pressure Measurement
  58. Essential hypertension in the pathogenesis of age-related macular degeneration
  59. Novel Inflammatory Indices in Aortic Disease
  60. An alternative method of percutaneous mitral valvuloplasty. Matching electrophysiology with interventional cardiology techniques
  61. Antithrombotic therapy in patients undergoing TAVI with concurrent atrial fibrillation. One center experience
  62. Percutaneous Closure of a Large Ascending Aorta Pseudoaneurysm Due to Mediastinitis Using an Amplatzer Occluder Device
  63. Vascular Sealing Implications in Transfemoral Transcatheter Aortic Valve Implantation
  64. Residual platelet reactivity after clopidogrel loading in ST-elevation myocardial infarction patients undergoing a delayed catheterization. Impact on long term clinical events
  65. Implicaciones del sellado vascular en el implante percutáneo transfemoral de válvula aórtica
  66. Percutaneous paravalvular leak closure after TAVI: A demanding approach
  67. Cardiac echo-lab productivity in times of economic austerity
  68. Effect of supine versus sitting position on noninvasive assessment of aortic pressure waveform: a randomized cross-over study
  69. Impact of inflammatory process on left ventricular recovery after Transcatheter Aortic Valve Implantation
  70. Non-invasive 24hour ambulatory monitoring of aortic wave reflection and arterial stiffness by a novel oscillometric device: The first feasibility and reproducibility study
  71. Predictive Factors of Vascular Complications after Transcatheter Aortic Valve Implantation in Patients Treated with a Default Percutaneous Strategy
  72. Troponin levels after TAVI are related to the development of distinct electrocardiographic changes
  73. MicroRNAs in Aortic Disease
  74. Quantitative analysis of carotid plaque vasa vasorum by CEUS and correlation with histology after endarterectomy
  75. Inferior epigastric artery as a landmark for transfemoral TAVI. Optimizing vascular access?
  76. Assessment of Left Atrial Function after Percutaneous Closure of Patent Foramen Ovale
  77. CoreValve deployment during cardiopulmonary resuscitation without angiographic injections guidance
  78. Feasibility and Reproducibility of Noninvasive 24-h Ambulatory Aortic Blood Pressure Monitoring With a Brachial Cuff-Based Oscillometric Device
  79. Effect of transcatheter aortic valve implantation on the ascending aorta’s elasticity
  80. Biomarkers as a Guide of Medical Treatment in Cardiovascular Diseases
  81. Residual Platelet Reactivity After Clopidogrel Loading in Patients With ST-Elevation Myocardial Infarction Undergoing an Unexpectedly Delayed Primary Percutaneous Coronary Intervention
  82. Trans-catheter aortic-valve implantation by the subclavian approach complicated with vessel dissection and transient left-arm paralysis
  83. “Bail out” procedures for malpositioning of aortic valve prosthesis (CoreValve)
  84. A 53-Year-Old Woman With Recurrent Transient Ischemic Attacks
  85. Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access
  86. CoreValve Aortic Bioprosthesis